0
Smith & Wesson Brands Inc — Q4 2026 Results (0HEM.L) — Investor Report
Smith Wesson Brands Inc [0HEM.L] LSE USD
What changed this quarter
Smith & Wesson Brands reported Q4 2026 revenue of $178.4 million, up 26.7% year‑over‑year and 31.5% sequentially. Gross profit was $53.1 million (29.8% gross margin). Operating income was $21.3 million (11.96% operating margin) and net income was $16.2 million (9.1% net margin), producing diluted EPS of $0.36. The company reports a strong conservative balance sheet with cash and short‑term investments of $33.35 million, no reported long‑term debt and shareholders' equity of $376.6 million. Inventory is elevated ($156.3 million) and working capital is sizeable; the current ratio is approximately 3.2x. Reported EBITDA is negative on a nonstandard basis due to large depreciation and amortization and non‑cash adjustments in the period; however operating income and net income are positive. Near‑term outlook depends on inventory normalization, demand stability and any further non‑cash accounting items that affect adjusted EBITDA.
Revenue and net income
Key insights
Selected Q4 2026 metrics (USD): Revenue $178.388M (+26.7% YoY; +31.5% QoQ); Gross profit $53.09M (29.76% margin); Operating income $21.341M (11.96% margin); Net income $16.222M (9.09% margin); Diluted EPS $0.36. Balance sheet: Cash & short‑term investments $33.352M; Total assets $512.766M; Total liabilities $136.207M; Total equity $376.559M; Net cash (no reported debt) ~$28.19M. Working capital: Current assets $241.403M; Current liabilities $75.367M; Current ratio ~3.2x. Inventory $156.25M (~64.7% of current assets; ~30.5% of total assets). Effective tax rate ~22.0%. Return metrics (simple): ROA ≈ 3.2%; ROE ≈ 4.3%.
Gross margin trend
Expense breakdown
Key financial ratios
Management commentary
Management commentary in the quarter emphasized top‑line growth driven by improved sales mix and channel restocking, with continued investment in manufacturing capacity and product development. Management acknowledged elevated inventory levels and stated they represent strategic positioning against supply chain variability and to support anticipated retailer demand. The company reiterated its conservative capital structure and focus on cash generation, while noting certain non‑cash accounting and depreciation items increased period volatility in EBITDA measures. No material long‑term debt was announced in the quarter; liquidity remains sufficient to fund operations and planned capital expenditure.
Management characterized the quarter as a solid revenue step with improving margins and highlighted inventory position as deliberate support for expected retail demand and supply‑chain resilience.
Company management (earnings release summary)
Company leadership noted the balance sheet remains conservative with no material long‑term debt and emphasized attention to converting elevated inventories back into free cash flow.
Company management (earnings release summary)
Forward guidance
Management did not provide detailed numeric multi‑quarter guidance in the disclosed materials. Based on reported results and balance sheet posture, the near‑term base case assumes: moderate revenue growth (single‑ to low‑double digits) if demand is sustained and channel inventories normalize; margins can be stable to modestly improved as fixed costs are absorbed, provided ASP and product mix remain favorable; cash generation should remain positive absent unexpected working capital swings, though free cash flow will depend on inventory reduction and capex timing. Key monitoring items for guidance revision: inventory trajectory, retail sell‑through, any further large non‑cash charges and macro/regulatory developments affecting consumer demand.
Peer margin comparison
Competitive snapshot
| Company | Gross margin | Operating margin | ROE | P/E |
|---|---|---|---|---|
| 0HEM.L | 29.76% | - | - | - |
| 0QI9.L | 0.00% | 0.00% | 2.82% | 8.53% |
| 0K05.L | 74.10% | 0.60% | 0.38% | 60.53% |
Investment outlook
Smith & Wesson's Q4 2026 results show accelerating revenue and positive operating profitability with a conservative capital structure. Key strengths for investors are the brand franchise, low leverage and improving margin profile. Primary concerns are the elevated inventory position, the unusual negative reported EBITDA on a non‑standard basis (driven by large depreciation/amortization and non‑cash items) and industry regulatory risk. For investors with a medium‑term horizon, the investment case is conditional: if management can convert inventory into cash without significant markdowns and maintain the improved sales trajectory, the company has scope to generate meaningful free cash flow and support shareholder returns or selective reinvestment. Near‑term valuation should reflect inventory risk, potential volatility in adjusted EBITDA, and regulatory uncertainty. Recommended focus for monitoring: quarterly inventory trends and days outstanding, adjusted EBITDA reconciliation and cash flow from operations, product sell‑through at retail, and any management commentary on regulatory exposure or capital allocation changes.
Strengths
- Recognizable consumer and institutional brands with diversified end markets (civilian, law enforcement, military).
- Conservative balance sheet: positive net cash position and no reported long‑term debt.
- Improving top‑line growth in Q4 2026 with positive operating and net income.
Weaknesses
- High inventory level relative to current assets and total assets, creating working capital intensity and potential markdown risk.
- Reported EBITDA is distorted by large non‑cash depreciation/amortization, complicating cash‑flow‑based valuation.
- Sales cyclicality and exposure to discretionary consumer spending and policy risk.
Opportunities
- Channel restocking and new product introductions could sustain near‑term revenue growth.
- Expansion of precision components and manufacturing services could diversify revenue and margin profile.
- Operational improvements to reduce inventory days and accelerate cash conversion would materially enhance free cash flow.
Threats
- Regulatory action or changes in firearms policy could reduce end‑market demand or increase compliance costs.
- Litigation, reputational issues or adverse publicity remain a persistent industry risk.
- Macroeconomic deterioration could depress discretionary purchases and lengthen inventory conversion.
